Early Intervention Crucial for Prostate Enlargement: Rethinking BPH Treatment

• Benign Prostatic Hyperplasia (BPH) is a common, progressive condition affecting men over 50, leading to lower urinary tract symptoms.
• Traditional medical therapies like alpha-blockers and 5-ARIs relieve symptoms but don't eliminate mechanical obstruction, allowing disease progression.
• Minimally Invasive Surgical Therapies (MISTs) like Prostatic Urethral Lift (PUL) offer early obstruction relief, preserving bladder and renal health.
• MISTs, such as UroLift, are performed under local anesthesia, preserve sexual function, and allow rapid recovery, making them suitable for patients with comorbidities.
• Early intervention with MISTs is crucial to prevent irreversible bladder damage and reduce long-term medication dependence, shifting BPH management focus.